A detailed history of Mission Creek Capital Partners, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Mission Creek Capital Partners, Inc. holds 1,854 shares of TMO stock, worth $1.03 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
1,854
Previous 1,095 69.32%
Holding current value
$1.03 Million
Previous $581,000 85.37%
% of portfolio
0.28%
Previous 0.15%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$528.82 - $599.43 $401,374 - $454,967
759 Added 69.32%
1,854 $1.08 Million
Q4 2023

Feb 14, 2024

SELL
$431.41 - $532.94 $2,157 - $2,664
-5 Reduced 0.45%
1,095 $581,000
Q3 2023

Nov 14, 2023

SELL
$498.29 - $574.41 $57,801 - $66,631
-116 Reduced 9.54%
1,100 $556,000
Q2 2023

Aug 14, 2023

SELL
$508.46 - $591.13 $3,050 - $3,546
-6 Reduced 0.49%
1,216 $634,000
Q4 2022

Feb 13, 2023

SELL
$484.71 - $571.37 $31,990 - $37,710
-66 Reduced 5.12%
1,222 $673,000
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $12,679 - $15,112
-25 Reduced 1.9%
1,288 $653,000
Q2 2022

Aug 15, 2022

SELL
$500.9 - $612.21 $10,018 - $12,244
-20 Reduced 1.5%
1,313 $713,000
Q1 2022

May 13, 2022

SELL
$524.0 - $644.92 $5,240 - $6,449
-10 Reduced 0.74%
1,333 $787,000
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $58,038 - $68,058
-102 Reduced 7.06%
1,343 $896,000
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $73,881 - $88,418
-145 Reduced 9.12%
1,445 $826,000
Q1 2021

May 14, 2021

SELL
$439.85 - $518.83 $65,977 - $77,824
-150 Reduced 8.62%
1,590 $726,000
Q1 2020

May 14, 2020

BUY
$255.3 - $340.05 $17,871 - $23,803
70 Added 4.19%
1,740 $493,000
Q4 2019

Feb 14, 2020

BUY
$271.93 - $328.04 $454,123 - $547,826
1,670 New
1,670 $543,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $217B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Mission Creek Capital Partners, Inc. Portfolio

Follow Mission Creek Capital Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Creek Capital Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mission Creek Capital Partners, Inc. with notifications on news.